More reads
- Meet the artificial embryos being called 'uncanny' and 'spectacular.' (MIT Technology Review)
- Why aren't there better cancer drugs? Scientists may have picked the wrong targets. (New York Times)
- Penn team repurposes CAR-T cancer tech to treat heart disease. (FierceBiotech)
No hay comentarios:
Publicar un comentario